Prospective prediction of spontaneous but not recurrent autoimmune diabetes in the non-obese diabetic mouse

Diabetologia

Volumn 50, Issue 5, 2007, Pages 1015-1023

  Trudeau, J D ^a,b   Chandler, T ^a,b   Soukhatcheva, G ^a,b   Verchere, C B ^a,b   Tan, R ^a,b  

^a BC CHILDREN S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Autoimmunity; MHC tetramers; NOD mice; T cells; Type 1 diabetes

Indexed keywords

GLUCOSE 6 PHOSPHATASE;

ALLOGRAFT; ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD SAMPLING; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXIC T LYMPHOCYTE; GRAFT FAILURE; GRAFT REJECTION; IMMUNOREACTIVITY; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; ISOGRAFT; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOIMMUNE DISEASES; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE-6-PHOSPHATASE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; PROTEINS; RECURRENCE; T-LYMPHOCYTES;

EID: 34147103973     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0600-9     Document Type: Article

References (24)

1. Liblau RS, Wong FS, Mars LT, Santamaria P (2002) Autoreactive CD8 T cells in organ-specific autoimmunity. Emerging targets for therapeutic intervention. Immunity 17:1-6
2. Wong FS, Karttunen J, Dumont C et al (1999) Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat Med 5:1026-1031
3. Lieberman SM, Evans AM, Han B et al (2003) Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+T cells in autoimmune diabetes. Proc Natl Acad Sci USA 100:8384-8388
4. Lieberman SM, Takaki T, Han B, Santamaria P, Serreze DV, DiLorenzo TP (2004) Individual nonobese diabetic mice exhibit unique patterns of CD8+T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase. J Immunol 173:6727-6734
5. Trudeau JD, Kelly-Smith C, Verchere CB et al (2003) Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest 111:217-223
6. Weir GC, Bonner-Weir S (1997) Scientific and political impediments to successful islet transplantation. Diabetes 46:1247-1256
7. Shapiro AM, Lakey JR, Ryan EA et al (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoidfree immunosuppressive regimen. N Engl J Med 343:230-238
8. Ryan EA, Paty BW, Senior PA et al (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54:2060-2069
9. Coulombe M, Gill RG (2004) The immunobiology of pancreatic islet transplantation. Adv Exp Med Biol 552:154-169
10. Amrani A, Serra P, Yamanouchi J et al (2001) Expansion of the antigenic repertoire of a single Tcell receptor upon Tcell activation. J Immunol 167:655-666
11. Lieberman SM, DiLorenzo TP (2003) A comprehensive guide to antibody and T-cell responses in type 1 diabetes. Tissue Antigens 62:359-377
12. Panagiotopoulos C, Trudeau JD, Tan R (2004) T-cell epitopes in type 1 diabetes. Curr Diab Rep 4:87-94
13. Pinkse GG, Tysma OH, Bergen CA et al (2005) Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc Natl Acad Sci USA 102:18425-18430
14. Diabetes Prevention Trial-Type 1 Diabetes Study Group (2002) Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 346:1685-1691
15. Hering BJ (1996) Insulin independence following islet transplantation in man a comparison of different recipient categories. Intern Islet Transpl Registry 6:5-19
16. Roep BO (2003) The role of T-cells in the pathogenesis of type 1 diabetes: from cause to cure. Diabetologia 46:305-321
17. Peck AB, Cornelius JG, Chaudhari M, Shatz D, Ramiya VK (2002) Use of in vitro-generated, stem cell-derived islets to cure type 1 diabetes: how close are we? Ann N Y Acad Sci 958:59-68
18. Ryu S, Kodama S, Ryu K, Schoenfeld DA, Faustman DL (2001) Reversal of established autoimmune diabetes by restoration of endogenous beta cell function. J Clin Invest 108: 63-72
19. Kodama S, Kuhtreiber W, Fujimura S, Dale EA, Faustman DL (2003) Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 302:1223-1227
20. Wong CP, Li L, Frelinger JA, Tisch R (2006) Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+T cells in diabetic nonobese diabetic mice. J Immunol 176:1637-1644
21. Han B, Serra P, Yamanouchi J et al (2005) Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes. J Clin Invest 115:1879-1887
22. Sprent J, Surh CD(2002) Tcellmemory. Annu Rev Immunol 20:551-579
23. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N (1998) Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 4:781-785
24. Han D, Xu X, Baidal D et al (2004) Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: elevation precedes clinical evidence of rejection. Diabetes 53:2281-2290